Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21WB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,107
Award facts
- Contract value 100% obligated
- $63,106.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (subsidiary of Cencora, Inc.) on February 4, 2026, for the supply of Dupixent 300 mg/2 ml pen injectors valued at $63,106.67 with a firm fixed price structure. This non-competitive set-aside delivery order is scheduled for completion by February 5, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, making this procurement essential for military healthcare support.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply distribution across military healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor, maintains a comprehensive federal contract portfolio supplying brand-name and generic medications, vaccines, and specialized medical commodities to support Defense Health Agency and other federal healthcare programs. The company's established capabilities in fulfilling large-scale federal medical procurement requirements through competitive awards demonstrate its critical role in the military supply chain.
Quick answers
Who was awarded contract SPE2DR26F21WB?
SPE2DR26F21WB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F21WB worth?
The government has obligated $63,107 on SPE2DR26F21WB.
Is contract SPE2DR26F21WB an order under another contract?
Yes. SPE2DR26F21WB is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21WB competed?
The extent of competition for SPE2DR26F21WB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award